| Study title |
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial To Evaluate The Efficacy Of Dupilumab (Anti-Il4ra) In Subjects With Eosinophilic Gastritis (DEGAS) |
| Disease or condition |
Eosinophilic Gastritis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Dupolumab or placebo |
| Phase |
2 |
| Study site |
University of North Carolina at Chapel Hill |
| Study location |
Chapel Hill |
| Principal investigator name and email |
Evan Dellon, MD, MPH cedas@med.unc.edu |
| Study coordinator name and email |
Wyatt Moorer, wwmoorer@email.unc.edu |
| Phone contact |
(919) 843-4480 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT03678545 |
